Advertisement
U.S. markets open in 9 hours 30 minutes
  • S&P Futures

    5,204.25
    -10.50 (-0.20%)
     
  • Dow Futures

    39,182.00
    -41.00 (-0.10%)
     
  • Nasdaq Futures

    18,163.75
    -67.75 (-0.37%)
     
  • Russell 2000 Futures

    2,045.30
    -4.50 (-0.22%)
     
  • Crude Oil

    82.53
    -0.19 (-0.23%)
     
  • Gold

    2,164.00
    -0.30 (-0.01%)
     
  • Silver

    25.29
    +0.03 (+0.10%)
     
  • EUR/USD

    1.0877
    0.0000 (-0.00%)
     
  • 10-Yr Bond

    4.3400
    +0.0360 (+0.84%)
     
  • Vix

    14.33
    -0.08 (-0.56%)
     
  • GBP/USD

    1.2724
    -0.0005 (-0.04%)
     
  • USD/JPY

    149.6830
    +0.5850 (+0.39%)
     
  • Bitcoin USD

    65,916.61
    -2,050.84 (-3.02%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,722.55
    -4.87 (-0.06%)
     
  • Nikkei 225

    39,753.11
    +12.67 (+0.03%)
     

SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against InfuSystem Holdings, Inc. and Encourages Investors with Losses to Contact the Firm

IRVINE, CA / ACCESSWIRE / December 29, 2016 / Khang & Khang LLP (the "Firm") announces a class action lawsuit against InfuSystem Holdings, Inc. ("InfuSystem" or the "Company") (NYSE MKT: INFU). Investors who purchased or otherwise acquired shares between May 12, 2015 and November 7, 2016 inclusive (the "Class Period"), are encouraged to contact the Firm before the January 9, 2017 lead plaintiff motion deadline.

If you purchased shares of InfuSystem during the Class Period, please contact Joon M. Khang, Esquire, of Khang & Khang LLP, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone: (949) 419-3834, or by e-mail at joon@khanglaw.com.

There has been no class certification in this case. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member.

The complaint alleges that InfuSystem made false and misleading statements and/or failed to disclose: that InfuSystem lacked effective internal control over financial reporting; that the Company's financial statements from back to the beginning of 2015 overstated the estimated accounts receivable collections, which then overstated revenues and pre-tax income by a corresponding amount; that financial statements dating back to the beginning of 2015 could no longer be relied upon; and that as a result of the above, the Company's financial statements were materially false and misleading at all relevant times. When this information was disclosed to the public, shares of InfuSystem declined in value, causing investors serious harm.

If you wish to learn more about this lawsuit, at no charge, or if you have any questions regarding this notice or your rights, please contact Joon M. Khang, a prominent litigator for almost two decades, by telephone: (949) 419-3834, or by e-mail at joon@khanglaw.com.

This press release may constitute Attorney Advertising in some jurisdictions.

Contact:

Joon M. Khang, Esq.
Telephone: 949-419-3834
Facsimile: 949-225-4474
joon@khanglaw.com

SOURCE: Khang & Khang LLP

Advertisement